🇺🇸 US FDA removes PABA and trolamine salicylate from sunscreen monograph M020
11 Sep 2027 · United States · Confidence: Secondary (authoritative)
What happens
The US Food and Drug Administration (FDA) issued Final Order OTC000008-1 on 10–11 September 2026, removing aminobenzoic acid (PABA) and trolamine salicylate from sunscreen monograph M020. FDA states that no products currently marketed in the US contain these two ingredients, so the practical impact is limited; however, it is the first time FDA has formally removed previously permitted sunscreen active ingredients, which is a significant signal.
What to do
Companies with US sunscreen lines should watch for further reviews of other active ingredients.
Source
FDA Final Order OTC000008-1
Pick your category — get recalls & regulation alerts weekly
Leave your email and the category you make: each week we tell you what was recalled or noticed in the EU and US, which deadlines are close, and who just raised money. Or use RSS. Free; unsubscribe anytime.
- EU recalls and US Prop 65 notices in your category
- Upcoming regulatory deadlines
- Opportunities filtered for your role